MONASH IVF GROUP LIMITED — Director's Dealing 2020

Mar 9, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Monash IVF Group Limited

ABN 90 169 302 309

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Note that this appendix 3Y notice updates the Appendix 3Y notice lodged on 11 August 2014 and now includes Part 3

Name of Director	Michael Damian Knaap
Date of last notice	15 April 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	9 March 2020
No. of securities held prior to change	54,444 Ordinary Shares Performance Rights  38,894 under the 2017 Equity Incentive Plan  59,360 under the 2018 Equity Incentive Plan  81,635 under the 2019 Equity Incentive Plan
Class	Ordinary Shares Performance Rights

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired	36,545 Ordinary Shares 294,410 Performance Rights as approved by shareholders at the Monash IVF Group Limited Annual General Meeting on 28 November 2019
Number disposed	38,894 performance rights lapsed under the 2017 Equity Incentive Plan
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Ordinary Shares value - $29,966.90 Performance Rights – N/A
No. of securities held after change	90,989 Ordinary Shares Performance Rights  59,360 under the 2018 Equity Incentive Plan  81,635 under the 2019 Equity Incentive Plan  294,410 under the 2020 Equity Incentive Plan as approved
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Ordinary shares purchased via On-market trade Performance Rights issued under the Equity Incentive Plan as approved by Shareholders at the 2017 AGM and a summary of terms of the EIP were included in the Notice of AGM lodgedwith the ASX on 23 October 2017.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	n/a
Nature of interest	n/a
Name of registered holder (if issued securities)	n/a
Date of change	n/a

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	n/a
Interest acquired	n/a
Interest disposed	n/a
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	n/a
Interest after change	n/a

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	n/a
If prior written clearance was provided, on what date was this provided?	n/a

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3